EvitarTM - Expands Post-Surgery Adhesion Market in Laparoscopy Surgery
Ready to address $2.5 billion US Global Market
I believe the approach has potential to set a new standard of care in gynecology pelvic surgeries. For me it is important that it is not a barrier or medical devices which are not that effective. Read More
TTX-330 Spinal is a drug and bioresorbable polymer combination that helps reduce peridural fibrosis following spinal surgery.
Healthcare leaders are stepping up efforts to diagnose and treat AKI. TTX-332 is a promising therapeutic strategy for the prevention of AKI, an area of high unmet medical need.
Chairman, Previous VP International Marketing, Abbott
SVP Business Development, Adherium LTD
Managing Director, Yorkville Advisors
CPA, CBV Previous Sr. Life science practice leader, Deloitte
CEO 4P Therapeutics Previous VP of Altea, Durect, Kimberly Clark
Mexican Businessman and Entrepreneur
CEO, Check-Cap, Ltd
Cancer surgery complication costs burden US healthcare JAN 13, 2014 The cost of complications from cancer surgery places a tremendous financial strain on the healthcare system, according to a new study.Read More
..only those technologies and innovations that offer rounded value to the clinic will stick. Increasingly ‘interventional’ (catheter-based) devices will offer less traumatic surgery by requiring less anaesthesia and quicker recovery, which will reduce intra- and post-operativeRead More
I believe the approach has potential to set a new standard of care in gynecology pelvic surgeries. For me it is important that it is not a barrier or medical devices which are not that effective... Read More